Search Results - "Medical Genetics and Genomics"

DNA methylation in cord blood partially mediates the effects of prepregnancy BMI on early childhood offspring BMI

Maguolo, Alice, Jönsson, Josefine, Perfilyev, Alexander, Maziarz, Marlena, Vaag, Allan, Malchau Carlsen, Emma, Nørgaard, Kirsten, Franks, Paul W, Renault, Kristina M, Ling, Charlotte

Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EXODIAB: Excellence of Diabetes Research in Sweden, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EXODIAB: Excellence of Diabetes Research in Sweden, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Celiac Disease and Diabetes Unit, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Celiaki och diabetes, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Diabetes - Epigenetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Diabetes - epigenetik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Translational Diabetes Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Translationell diabetesforskning, Originator, Lund University, Faculty of Medicine, WCMM-Wallenberg Centre for Molecular Medicine, Lunds universitet, Medicinska fakulteten, WCMM- Wallenberg center för molekylär medicinsk forskning, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Genetic and Molecular Epidemiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Genetisk och molekylär epidemiologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

Characterizing the allele-specific gene expression landscape in high hyperdiploid acute lymphoblastic leukemia with BASE

Andersson, Jonas, Aydin, Efe, Gunnarsson, Rebeqa, Lilljebjörn, Henrik, Fioretos, Thoas, Johansson, Bertil, Paulsson, Kajsa, Yang, Minjun

Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Genetics and Diabetes, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Genetik och diabetes, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Aneuploidy in cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Aneuploidi i cancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Genetic and epigenetic studies of pediatric leukemia, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Genetiska och epigenetiska studier av barnleukemi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Translational Genomic and Functional Studies of Leukemia, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Translationella genomiska och funktionella studier av leukemi, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator

Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases

Thorsson, Hanna, Henningsson, Rasmus, Puente-Moncada, Noelia, Peña-Martínez, Pablo, Sjöström, Ludvig, Ågerstam, Helena, Sandén, Carl, Rissler, Marianne, Castor, Anders, Marquart, Hanne, Modvig, Signe, Paulsson, Kajsa, Pronk, Cornelis Jan, Schmiegelow, Kjeld, Hyrenius-Wittsten, Axel, Orsmark-Pietras, Christina, Lilljebjörn, Henrik, Fioretos, Thoas

Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Translational Genomic and Functional Studies of Leukemia, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Translationella genomiska och funktionella studier av leukemi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Targeted therapies in leukemia, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Målinriktade behandlingar för leukemi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Aneuploidy in cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Aneuploidi i cancer, Originator, Lund University, Faculty of Medicine, WCMM-Wallenberg Centre for Molecular Medicine, Lunds universitet, Medicinska fakulteten, WCMM- Wallenberg center för molekylär medicinsk forskning, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Paediatrics (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Pediatrik, Lund, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Molecular Hematology (DMH), Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för molekylär hematologi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Synthetic Immunology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Syntetisk immunologi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, The pathogenetic mechanisms behind MLL-rearranged acute leukemia in infancy, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, MLL-rearrangerad leukemi hos spädbarn, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator

Epigenome-wide association study of objectively measured physical activity in peripheral blood leukocytes

Fragoso-Bargas, Nicolas, Mcbride, Nancy S, Lee-Ødegård, Sindre, Lawlor, Deborah A, Yousefi, Paul D, Moen, Gunn-Helen, Opsahl, Julia O, Jenum, Anne Karen, Franks, Paul W, Prasad, Rashmi B, Qvigstad, Elisabeth, Birkeland, Kåre I, Richardsen, Kåre R, Sommer, Christine

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Clinical Sciences, Helsingborg, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Kliniska Vetenskaper, Helsingborg, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Genetic and Molecular Epidemiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Genetisk och molekylär epidemiologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EXODIAB: Excellence of Diabetes Research in Sweden, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EXODIAB: Excellence of Diabetes Research in Sweden, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Genetics and Diabetes, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Genetik och diabetes, Originator

Whole genome sequencing in early onset advanced heart failure

Linnér, Erik, Czuba, Tomasz, Gidlöf, Olof, Lundgren, Jakob, Bollano, Entela, Hellberg, Maria, Celik, Selvi, Pimpalwar, Neha, Rentzsch, Philipp, Martorella, Molly, Gummesson, Anders, Melander, Olle, Albinsson, Sebastian, Dellgren, Göran, Borén, Jan, Jeppsson, Anders, Lumbers, R. Thomas, Shah, Sonia, Nilsson, Johan, Natarajan, Pradeep, Lappalainen, Tuuli, Levin, Malin, Ehrencrona, Hans, Smith, J. Gustav

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Cardiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Kardiologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EXODIAB: Excellence of Diabetes Research in Sweden, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EXODIAB: Excellence of Diabetes Research in Sweden, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Cardiology, Molecular Epidemiology and Cardiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Kardiologi, Molecular Epidemiology and Cardiology, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Cardiology, Molecular Cardiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Kardiologi, Molekylär kardiologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Cardiology, Cardiovascular Epigenetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Kardiologi, Cardiovascular Epigenetics, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Cardiology, Lund Hemodynamic Lab, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Kardiologi, Lund Hemodynamic Lab, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Hematology and Clinical Immunology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för hematologi och klinisk immunologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Cardiovascular Research - Hypertension, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Kardiovaskulär forskning - hypertoni, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Molecular Vascular Physiology, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Molekylär kärlfysiologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Artificial Intelligence and Bioinformatics in Cardiothoracic Sciences (AIBCTS), Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Artificiell intelligens och bioinformatik inom thoraxkirurgisk vetenskap, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, Heart and Lung transplantation, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, Hjärt- och lungtransplantation, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, Heparin bindning protein in cardiothoracic surgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, Heparinbindande protein inom thoraxkirurgi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, WCMM-Wallenberg Centre for Molecular Medicine, Lunds universitet, Medicinska fakulteten, WCMM- Wallenberg center för molekylär medicinsk forskning, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Cardiology, Heart Failure and Mechanical Support, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Kardiologi, Heart Failure and Mechanical Support, Originator

Characterisation of heritable TP53-related cancer syndrome in Sweden—a nationwide study of genotype-phenotype correlations in 90 families

Omran, Meis, Liu, Yaxuan, Sun Zhang, Alexander, Poluha, Anna, Stenmark-Askmalm, Marie, Persson, Fredrik, Hallbeck, Anna Lotta, Rosén, Anna, Helgadottir, Hafdis T., Tham, Emma, Bajalica-Lagercrantz, Svetlana

Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Originator

Benchmarking Alzheimer’s disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies

Mattsson-Carlgren, Niklas, Hansson, Oskar, Alzheimer's Disease Neuroimaging Initiative

Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Clinical Memory Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Klinisk minnesforskning, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Proactive Ageing, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Proaktivt åldrande, Originator

PON-P3: Accurate Prediction of Pathogenicity of Amino Acid Substitutions

Kabir, Muhammad, Ahmed, Saeed, Zhang, Haoyang, Rodríguez-Rodríguez, Ignacio, Najibi, Seyed Morteza, Vihinen, Mauno

Lund University, Faculty of Medicine, Department of Experimental Medical Science, Protein Bioinformatics, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Proteinbioinformatik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section III, Rheumatology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion III, Reumatologi och molekylär skelettbiologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Faculty of Science, Department of Chemistry, Center for Molecular Protein Science, Biochemistry and Structural Biology, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Centrum för Molekylär Proteinvetenskap, Biokemi och Strukturbiologi, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator

Pathogenic KIAA0586/TALPID3 variants are associated with defects in primary and motile cilia

Taudien, Jacqueline E., Bracht, Diana, Olbrich, Heike, Swirski, Sebastian, D'Abrusco, Fulvio, Van der Zwaag, Bert, Möller, Maike, Lücke, Thomas, Teig, Norbert, Lindberg, Ulrika, Wohlgemuth, Kai, Wallmeier, Julia, Blanque, Anja, Gatsogiannis, Christos, George, Sebastian, Jüschke, Christoph, Owczarek-Lipska, Marta, Veer, Dorothee, Kroes, Hester Y., Valente, Enza Maria, Korenke, G. Christoph, Omran, Heymut, Neidhardt, John

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Respiratory Medicine, Allergology, and Palliative Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Lungmedicin, allergologi och palliativ medicin, Originator

The fifth international hackathon for developing computational cloud-based tools and resources for pan-structural variation and genomics

Deb, Sontosh K, Kalra, Divya, Kubica, Jędrzej, Stricker, Erik, Truong, Van Q, Zeng, Qiandong, Fiscus, Christopher J, Agustinho, Daniel Paiva, Alexander, Adam, Arciniega-Sanchez, Marlon, Bosseau, Lorianne, Brueffer, Christian, Canal, Astrid, Daw, Joyjit, Enoma, David, Diaz-Cuevas, Alison, Diesh, Colin, Doolittle-Hall, Janet M, Fernandez-Luna, Luis, Han, Tina, Höps, Wolfram, Huang, Peiming Peter, Huang, Tony, Izydorczyk, Michal Bogumil, Jaryani, Farhang, Kesharwani, Rupesh K, Khan, Shaheerah, Majidian, Sina, Malakar, Ayan, Mangolini, Tania Girão, Modha, Sejal, Moldes, Mauricio, Mondal, Rajarshi, Al Nahid, Abdullah, Poon, Chi-Lam, Sagayaradj, Sagayamary, Sanio, Philippe, Sepulveda-Morales, Tania, Shahzaib, Muhammad, Raza, Muhammad Sohail, Tat, Trinh, Thota, Ishaan, Yaman, Umran, Yeung, Jason, Yu, Qiyi, Zheng, Xinchang, Mahmoud, Medhat, Sedlazeck, Fritz J., Busby, Ben

Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Transl oncogenomics, Translational Oncogenomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Transl onkogenomik, Translational Oncogenomics, Originator

The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

Lundtoft, Christian, Knight, Ann, Meadows, Jennifer R S, Karlsson, Åsa, Rantapää-Dahlqvist, Solbritt, Berglin, Ewa, Palm, Øyvind, Haukeland, Hilde, Gunnarsson, Iva, Bruchfeld, Annette, Segelmark, Mårten, Ohlsson, Sophie, Mohammad, Aladdin J, Eriksson, Per, Söderkvist, Peter, Ronnblom, Lars, Omdal, Roald, Jonsson, Roland, Lindblad-Toh, Kerstin, Dahlqvist, Johanna

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Nephrology, Autoimmunity and kidney diseases, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Njurmedicin, Autoimmunitet och njursjukdomar, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section III, Rheumatology, Lund Vasculitis Epidemiology Research Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion III, Reumatologi och molekylär skelettbiologi, Lund Vasculitis Epidemiology Research Group, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section III, Orthopaedics (Lund), Lund OsteoArthritis Division - Clinical Epidemiology Unit, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion III, Ortopedi, Lund, Lund OsteoArthritis Division - Clinical Epidemiology Unit, Originator

Transcription factor-mediated reprogramming to antigen-presenting cells

Ascic, Ervin, Pereira, Carlos-Filipe

Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Molecular Medicine and Gene Therapy, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för molekylärmedicin och genterapi, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Molecular Medicine and Gene Therapy, Cell Reprogramming in Hematopoiesis and Immunity, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för molekylärmedicin och genterapi, Cellulär omprogrammering i hematopoes och immunitet, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of stem cell research, Stem Cell Center, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för stamcellsforskning, Stamcellscentrum (SCC), Originator, Lund University, Faculty of Medicine, WCMM-Wallenberg Centre for Molecular Medicine, Lunds universitet, Medicinska fakulteten, WCMM- Wallenberg center för molekylär medicinsk forskning, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Originator

A national long-read sequencing study on chromosomal rearrangements uncovers hidden complexities

Eisfeldt, Jesper, Ameur, Adam, Lenner, Felix, Berk de Boer, Esmee Ten, Ek, Marlene, Wincent, Josephine, Vaz, Raquel, Ottosson, Jesper, Jonson, Tord, Ivarsson, Sofie, Thunström, Sofia, Topa, Alexandra, Stenberg, Simon, Rohlin, Anna, Sandestig, Anna, Nordling, Margareta, Palmebäck, Pia, Burstedt, Magnus, Nordin, Frida, Stattin, Eva Lena, Sobol, Maria, Baliakas, Panagiotis, Bondeson, Marie Louise, Höijer, Ida, Saether, Kristine Bilgrav, Lovmar, Lovisa, Ehrencrona, Hans, Melin, Malin, Feuk, Lars, Lindstrand, Anna

Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Originator

Germline copy number variants and endometrial cancer risk

Stylianou, Cassie E., Wiggins, George A.R., Lau, Vanessa L., Dennis, Joe, Shelling, Andrew N., Wilson, Michelle, Sykes, Peter, Amant, Frederic, Annibali, Daniela, De Wispelaere, Wout, Easton, Douglas F., Fasching, Peter A., Glubb, Dylan M., Goode, Ellen L., Lambrechts, Diether, Pharoah, Paul D.P., Scott, Rodney J., Tham, Emma, Tomlinson, Ian, Bolla, Manjeet K., Couch, Fergus J., Czene, Kamila, Dörk, Thilo, Dunning, Alison M., Fletcher, Olivia, García-Closas, Montserrat, Hoppe, Reiner, Sachchithananthan, Mythily, Dinny Graham, J., Simpson, Peter, Pathmanathan, Nirmala, Davis, Alison, Carpenter, Jane, Yip, Desmond, Baxter, Robert, Scott, Rodney, Marsh, Deborah, Clarke, Christine, Jernström, Helena, Kaaks, Rudolf, Michailidou, Kyriaki, Obi, Nadia, Southey, Melissa C., Stone, Jennifer, Wang, Qin, Spurdle, Amanda B., O’Mara, Tracy A., Pearson, John, Walker, Logan C., ABCTB Investigators

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Cancerepidemiology and radiation, Epidemiology and pharmacogenetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Cancerepidemiologi & strål, Epidemiologi och farmakogenetik, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

The insertion/deletion polymorphism rs201494641 at ITGA9 influences blood CD34+ cell levels by altering ZNF384 binding

Cafaro, Caterina, Ali, Zain, Lamarca, Antton, Di Bello, Daniela Torres, Lozano, Laura Duran, Ekdahl, Ludvig, Thodberg, Malte, Pertesi, Maroulio, Lopez de Lapuente Portilla, Aitzkoa, Nilsson, Björn

Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Hematology and Clinical Immunology, Hematogenomics, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för hematologi och klinisk immunologi, Hematogenomics, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Hematology and Clinical Immunology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för hematologi och klinisk immunologi, Originator, Lund University, Joint Faculties of Humanities and Theology, Departments, Department of Archaeology and Ancient History, Archaeology, Lunds universitet, Humanistiska och teologiska fakulteterna, Institutioner, Institutionen för arkeologi och antikens historia, Arkeologi, Originator, Lund University, Joint Faculties of Humanities and Theology, Departments, Department of Archaeology and Ancient History, Digital Archaeology Laboratory DARK Lab, Lunds universitet, Humanistiska och teologiska fakulteterna, Institutioner, Institutionen för arkeologi och antikens historia, Digital Arkeologi Laboratoriet DARK Lab, Originator, Lund University, Joint Faculties of Humanities and Theology, Research platforms, HT, DIAD (Digital Integration Across Disciplines) Advancing Cultural Heritage Documentation, Lunds universitet, Humanistiska och teologiska fakulteterna, Forskningsplattformar, HT, DIAD (Digital Integration Across Disciplines) Advancing Cultural Heritage Documentation, Originator

A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer

Srinivasan, Srilakshmi, Melander, Olle, Dahlin, Anders, Häggström, Christel, Lilja, Hans, Eeles, Rosalind, The IMPACT Study, The Profile Study Steering Committee, PRACTICAL consortium, The Australian Prostate Cancer BioResource

Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EXODIAB: Excellence of Diabetes Research in Sweden, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EXODIAB: Excellence of Diabetes Research in Sweden, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Cardiovascular Research - Hypertension, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Kardiovaskulär forskning - hypertoni, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Internal Medicine - Epidemiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Internmedicin - epidemiologi, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Chemistry, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk kemi, Malmö, Originator

Understanding the genetic complexity of puberty timing across the allele frequency spectrum

Kentistou, K.A., Jernström, H., Ong, Ken K., ABCTB Investigators, Lifelines Cohort Study, Danish Blood Donor Study, Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, The Biobank Japan Project, China Kadoorie Biobank Collaborative Group

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Cancerepidemiology and radiation, Epidemiology and pharmacogenetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Cancerepidemiologi & strål, Epidemiologi och farmakogenetik, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Cancerepidemiology and radiation, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Cancerepidemiologi & strål, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

Genetic counselling legislation and practice in cancer in EU Member States

McCrary, J. Matt, Van Valckenborgh, Els, Poirel, Hélène A., de Putter, Robin, van Rooij, Jeroen, Horgan, Denis, Dierks, Marie Luise, Antonova, Olga, Brunet, Joan, Chirita-Emandi, Adela, Colas, Chrystelle, Dalmas, Miriam, Ehrencrona, Hans, Grima, Claire, Janavičius, Ramūnas, Klink, Barbara, Koczok, Katalin, Krajc, Mateja, Lace, Baiba, Leitsalu, Liis, Mistrik, Martin, Paneque, Milena, Primorac, Dragan, Roetzer, Katharina M., Ronez, Joelle, Slámová, Lucie, Spanou, Elena, Stamatopoulos, Kostas, Stoklosa, Tomasz, Strang-Karlsson, Sonja, Szakszon, Katalin, Szczałuba, Krzysztof, Turner, Jacqueline, van Dooren, Marieke F., van Zelst-Stams, Wendy A.G., Vassallo, Loredana Maria, Wadt, Karin A.W., Žigman, Tamara, Ripperger, Tim, Genuardi, Maurizio, Van den Bulcke, Marc, Bergmann, Anke Katharina

Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator

Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance

Thomsen, Hauke, Chattopadhyay, Subhayan, Weinhold, Niels, Vodicka, Pavel, Vodickova, Ludmila, Hoffmann, Per, Nöthen, Markus M., Jöckel, Karl Heinz, Schmidt, Börge, Hajek, Roman, Hallmans, Göran, Pettersson-Kymmer, Ulrika, Späth, Florentin, Goldschmidt, Hartmut, Hemminki, Kari, Försti, Asta

Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Molecular Pediatric Oncology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Molekylär barnonkologi, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Pathways of cancer cell evolution, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Cancercellers evolution, Originator

Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits

Keaton, J.M., Melander, O., The Million Veteran Program, Lifelines Cohort Study, CHARGE Consortium, ICBP Consortium, Warren, H.R.

Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Cardiovascular Research - Hypertension, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Kardiovaskulär forskning - hypertoni, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EXODIAB: Excellence of Diabetes Research in Sweden, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EXODIAB: Excellence of Diabetes Research in Sweden, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Originator